Ryoto Ozaki
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Japanese participant data from three gantenerumab trials in early Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: September 25, 2024
Final Analysis Results from the AGEHA Study: Emicizumab Prophylaxis for Acquired Hemophilia A with or without Immunosuppressive Therapy.
Journal: Thrombosis and haemostasis
Published: August 12, 2024
Planning and Implementing Master Protocol Trials in Japan: Key Considerations of the Japanese Guideline.
Journal: Clinical pharmacology and therapeutics
Published: July 10, 2024
Tocilizumab in combination with standard of care in patients with severe COVID-19 pneumonia: Efficacy and safety from a phase 3 clinical trial in Japan.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: December 15, 2023
Comparative effectiveness of tocilizumab vs standard care in patients with severe COVID-19-related pneumonia: a retrospective cohort study utilizing registry data as a synthetic control.
Journal: BMC infectious diseases
Published: April 27, 2023
Treatment pattern and changes in oral glucocorticoid dose after tocilizumab treatment in patients with adult Still's disease: An analysis of a Japanese claims database.
Journal: International journal of rheumatic diseases
Published: January 13, 2023
A prospective, multicenter, open-label phase III study of emicizumab prophylaxis in patients with acquired hemophilia A.
Journal: Journal of thrombosis and haemostasis : JTH
Published: June 09, 2022
Information criteria for detecting change-points in the Cox proportional hazards model.
Journal: Biometrics
Published: April 21, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026